Volver a Agenda
Session Chair(s)
Chih-Hwa Wallace Lin, PHD
Researcher and Acting Director, Biotechnology Unit
Board of Science and Technology, Executive Yuan, ROC, Taiwan
Learning Objective : Discuss the advancement of good manufacturing practices (GMP) and the Pharmaceutical Inspection Cooperation Scheme (PIC/S) GMP in the Asia Pacific region; Compare the development of GMP among Asian countries such as China, Japan, Korea, and Taiwan; Describe the impact on regulatory affairs and on industry.
Speaker(s)
TFDA Point of View
Ming-kung Yeh, PHD
TFDA, Taiwan
Director-General
PMDA Point of View
Takashi Nagashima
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
GMP Expert, Office of GMP/QMS Inspection
Industry Perspective
Michael Cutter
Novartis Pharma AG, Switzerland
Senior Director, Group Compliance and Auditing
¿Tiene una cuenta?